TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change From Baseline on Clinical COPD Questionnaire (CCQ) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Program acceptability - young adult
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Program acceptability - parent
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Program acceptability - provider
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Differences in gene expression related to innervation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants With AVN After 9 Months
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline in intraepidermal nerve fiber density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Spine Bone Mineral Density T Score Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ADP-induced % Maximum Platelet Aggregation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change From Baseline in UCLA PTSD Reaction Index (Child Self-report)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in UCLA PTSD Reaction Index (Parent Report)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Inta- and Peri-procedural Events
Endpoint domain: Adverse events/effects
Primary endpoint: Time to rescue therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to use Clearblue Advanced Fertility Monitor
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Copenhagen Burnout Inventory score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage Surface Microhardness Recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bowel Preparation using the Harefield Cleansing Scale (HCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of participants with follicular rupture delay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Simplified Oral Hygiene Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients responding according to DAS28 criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric Emptying of Solids Half-time (T1/2) at 5 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gastric Emptying of Solids Half-time (T1/2) at 16 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in MCCB score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of patients presenting clinically acceptable conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain function assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Premenstrual Tension Scale (PMTS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency, duration, and severity of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of clinically significant laboratory abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Dynamometer Testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensory Exam Testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission Rate
Endpoint domain: Physiological/clinical
Primary endpoint: Leptin Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of brachial plexus injury
Endpoint domain: Adverse events/effects
Primary endpoint: Tolerability Assessment of Wilate Infusions
Endpoint domain: Adverse events/effects
Primary endpoint: Host response to RV challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: satisfaction (treatment interference)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knee Active Flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Peripheral blood CD8 CTL responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma HIV-1 RNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in adenoma detection rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Internal organ involvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who discontinue the study due to adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Attentional performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Time to Complete Deairing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Reporting Vaccine-associated Unsolicited Non-serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: General Oral Health Assessment Index (GOHAI) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: FVC/DLCO values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accuracy of interim plasma cell free DNA genotyping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Styloid chain calcification pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Styloid processes length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conners' Adult ADHD Rating Scale-Observer Report
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of implantation of a right atrial lead
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain during drug administration or blood collection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with secondary infection
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of married individuals who have received couples' HCT
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to normal trace in each aEEG channel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl Meyer Assessment, upper extremity motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacterial colonization of the upper and lower airway
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cmax - Maximum Observed Concentration for Total Ursodiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-72 - Area Under the Concentration-time Curve From Time Zero to 72 Hours for Total Ursodiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in error rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modulation of EEG spectral power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of treatment at 20 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Victorian Institute of Sport Assessment Patellar outcome score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of vCP205 vaccinations
Endpoint domain: Adverse events/effects
Primary endpoint: Absolute change from baseline in glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Absolute change from baseline in insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Absolute change from baseline in free fatty acids (FFA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: New diagnosis of type 2 diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total calorie intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total fluid intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Meal duration during an ad libitum test meal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of glabellar rhytide reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of intubation and mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Vascular endothelial growth factor (VEGF) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Percentage of Participants with Immune-Mediated Adverse Events (imAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Root Coverage Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-surgical Clinical Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Gingival Fluid Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intima-media thickness of the carotid artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Knee Injury and Osteoarthritis Outcome Score - Joint Replacement (KOOS-JR)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Serum thyroglobulin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Thiol-Disulfide Homeostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ischemia Modified Albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Carriage of Virulent Sequence Types of Neisseria Meningitidis Group B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Combined Carriage of N. Meningitidis Serogroups A, C, W and Y
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: adenosine release in brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pain intensity difference (PID)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients surviving 30 days after the surgery
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients suffering from major cardiovascular event during 30 days after the surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of patients suffering from postoperative delirium during 7 days after the surgery
Endpoint domain: Adverse events/effects
Primary endpoint: DHA Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: EPA Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: level of children's emotional and stress symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: level of children's positive and negative behaviors
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: level of children's stress symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall procedural time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: tumor cell metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: new vessel formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of responders to the SRI-8 composite responder index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptomatic relief of diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Clustering of common lifestyle behaviours
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Ocular Inflammation Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Less Than 11 Tender Points at Month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of Participants With Less Than 11 Tender Points at Month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean Total Hip Percent Change in Bone Mineral Density (BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean Lumbar Spine Percent Change in Bone Mineral Density (BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Glucose Disposal Rate (GDR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: anastomotic leaks rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: PRN drug use in LTC residents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cultured Cell Exosome Protein Signature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anticipated Stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceived Community Stigma
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Enacted Stigma
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Proportion of patients maintaining MMR after treatment de-escalation and cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: considerable dyspnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Pancreatic Cysts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement in perception of pneumonia and recurrent wheeze
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cytokine release syndrome rate
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of severe CAD (stenosis >70%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with 50% reduction in PHQ-9 score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pupillary response to light
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Biopsy Proven Acute Rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Chronic Allograft Nephropathy/Interstitial Fibrosis and Tubular Atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Normal Renal Biopsy with Stable, Good Kidney Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: RBC Transfusion Independence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose Goal Attainment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Study-Related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Diabetes-related preventable hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Percentage of patients achieving well-controlled asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ERAS bundle compliance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in abdominal bloating sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage Surface Micro-hardness Recovery (SMHR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left ventricular velocity of circumferential shortening to left ventricular end systolic stress ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in mean attachment level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Polysomnography Data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Frequency of glycaemic screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequency of lipid profile screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequency of liver and renal function assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of sessions of gambling abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Suicidal behaviours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve From Time Zero Extrapolated to Infinite Time (AUC [INF])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time Taken for Plasma Concentration to Reduce by 50 Percent or Apparent Terminal Plasma Elimination Half-life (T Half)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with Modified Ranking Scale (mRS) (0-3) at 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Acne Scarring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of Fights in last 30 days
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Patient-reported medication adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Anxiety Improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: quantification of amyloid binding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Count of Participants With Positive and Negative 18F-FDG PET CT and F18-NaF PET CT Imaging Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Count of Participants With Positive DCE-MRI Imaging Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Hematocrit (Hct) at 36 Wks Post Menstrual Age (PMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hematological Dose Limiting Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Non-Hematological Dose Limiting Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the plasma concentration curve (AUC0-t) of doxylamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration (Cmax) of doxylamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing profile of cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of All Adverse Drug Reactions (ADRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence Rate of All Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Grade of metallic bar dislodgment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: cardiac toxicity event free survival
Endpoint domain: Mortality/survival
Primary endpoint: Patient-Reported Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Syncopal relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Time in Range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve from time zero to last measurable time point (AUC (0-t))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve from time zero to infinity (AUC (0-∞))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSA Progression Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Quit smoking status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to Clinical Pregnancy
Endpoint domain: Life impact
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Rate of allogenic transfusion with red blood cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: change in the proportion of patients with CIPN severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of severe IVH or death
Endpoint domain: Mortality/survival
Primary endpoint: Median duration of the intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Median radiation dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need of corrective interventions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: number of WEBs opened
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: visual analog scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Pain